xamoterol has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ardestani, PM; Coutellier, L; Evans, AK; Nguyen, T; Shamloo, M; Yi, B | 1 |
| Bader, PL; Belichenko, P; Encarnacion, A; Faizi, M; Kleschevnikov, A; Mobley, WC; Priestley, M; Saw, N; Shamloo, M; Tsien, RW; Tun, C | 1 |
2 other study(ies) available for xamoterol and Disease Models, Animal
| Article | Year |
|---|---|
Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist.
Topics: Adrenergic beta-1 Receptor Agonists; Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; beta-Arrestins; Brain; Cell Line, Tumor; CHO Cells; Cricetulus; Cyclic AMP; Disease Models, Animal; HEK293 Cells; Humans; Inflammation; Mice, Transgenic; Microglia; Neuroprotective Agents; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1; RNA, Messenger; Xamoterol | 2017 |
Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancer.
Topics: Animals; Behavior, Animal; Cognition Disorders; Disease Models, Animal; Down Syndrome; Female; Male; Mice; Mice, Mutant Strains; Mice, Transgenic; Nootropic Agents; Norepinephrine; Phenotype; Receptors, Adrenergic, beta-1; Xamoterol | 2011 |